• SEC Filings
Novelis
YearTrailing 12-MonthsCalendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011Calendar Year 2010Calendar Year 2009Calendar Year 2008Calendar Year 2007Calendar Year 2006Calendar Year 2005Calendar Year 2004
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Mergers & AcquisitionsProxy & Information StatementsOther
FormDescriptionDateFormat
CT ORDERConfidential treatment orderJul 30, 2012Open Confidential treatment order in HTML.Open Confidential treatment order in DOC file.Open Confidential treatment order in PDF file.Open Confidential treatment order in XLS file.
CT ORDERConfidential treatment orderJul 30, 2012Open Confidential treatment order in HTML.Open Confidential treatment order in DOC file.Open Confidential treatment order in PDF file.

Investor Contact

Megan Cochard
Director, Investor Relations
+1 404 760 4170
megan.cochard@novelis.adityabirla.com

Media Contacts

Novelis Corporate Headquarter​s​

Julie Groover
Director, Corporate Communications
+1 404 316-7525
E-Mail

 

North America

Fiona Bell
Director, Communications & Government Affairs
Novelis North America
+1 404 760 6585
E-Mail​

 

South America

Priscila Freitas
Manager, External Communications
Novelis South America
+55 11 5503 0834
E-Mail​

 

Europe

Mélanie Lambelet Martin
Director, Communications & Government Affairs
Novelis Europe
+ 41 44 386 2150
E-Mail​​​

 

Asia

ChiHyang Chung
Director, Communications and Government Affairs
Novelis Asia
+82 2 2259 1606
E-Mail​​​​​